Barrington Strategic Wealth Management Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$553K Sell
2,700
-40
-1% -$9.3K 0.28% 83
2017
Q2
$666K Sell
2,740
-75
-3% -$17.6K 0.34% 76
2017
Q1
$673K Sell
2,815
-90
-3% -$21K 0.35% 74
2016
Q4
$610K Buy
2,905
+26
+0.9% +$5.39K 0.33% 76
2016
Q3
$663K Buy
2,879
+594
+26% +$145K 0.37% 72
2016
Q2
$528K Buy
+2,285
New +$527K 0.3% 78

Other funds holding AGN

Barrington Strategic Wealth Management Group's AGN Position: Q3 2017 in Review

Barrington Strategic Wealth Management Group reduced its Allergan plc (AGN) stake by 1.5% in Q3 2017, selling an estimated $9.3K and leaving 2,700 shares worth $553K. The position accounts for 0.28% of the portfolio, ranked #83.

Barrington Strategic Wealth Management Group first reported a position in AGN in Q2 2016 and has held it in 6 quarters since. The position peaked at $673K in Q1 2017. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Barrington Strategic Wealth Management Group held 2,700 shares of Allergan plc worth $553K as of Q3 2017.
  • Barrington Strategic Wealth Management Group sold 40 Allergan plc shares in Q3 2017, an estimated $9.3K.
  • Allergan plc made up 0.28% of Barrington Strategic Wealth Management Group's portfolio in Q3 2017, its #83 holding.
  • Barrington Strategic Wealth Management Group first reported a position in Allergan plc in Q2 2016 and has held it in 6 quarters since.
  • Barrington Strategic Wealth Management Group's Allergan plc position peaked at $673K in Q1 2017.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Barrington Strategic Wealth Management Group's 13F filing for Q3 2017, filed 31 Oct 2017.